Due to a lack of clarity in the original news report, a summary in Monday's FDLI SmartBrief stated that Purdue Pharma said Palladone, its recently approved analgesic, may be more difficult to misuse than OxyContin. Purdue Pharma says it does not claim that Palladone, which has been approved by the FDA, is abuse-resistant or more difficult to misuse than OxyContin.

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN